NEW YORK, Aug 29 – Oxagen of Abingdon, UK, and Cerylid Biosciences of Melbourne, said Wednesday that they had agreed to collaborate to jointly study the genetic basis of endometriosis. 

Oxagen and Cerylid are planning to look for genes and SNPs that lead to endometriosis and to eventually find targets that will lead to new diagnostics and treatments for the disease, which is estimated to affect as many as 10 percent of women of reproductive age, the companies said. 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The New York City medical examiner is overseeing an effort to identify missing persons using DNA, according to the Associated Press.

Nobel laureate Günter Blobel has died at 81, the New York Times reports.

In PNAS this week: mouse model of genetically induced emphysema, gene expression signatures of circulating melanoma cells, and more.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.